LEADERSHIP TEAM

LEADERSHIP TEAM PROFILES

Our leadership team is proud to uphold the core values, vision and mission for Alexium associates and our investors.

WILLIAM "BILLY" BLACKBURN

WILLIAM "BILLY" BLACKBURN

Chief Executive Officer

Billy Blackburn joined Alexium with 25 years’ experience and a successful record of product commercialization and driving profitable revenue growth. He is a graduate of the University of South Carolina business school. He specializes in driving growth in businesses with technical offerings. He has led the startup, growth and sale of a specialty chemical business focused on sustainability and high-purity chemistry. He has led companies through successful turnarounds via positive culture changes that shifted organizational focus to customers and world class service.

DR. ROBERT "BOB" BROOKINS

DR. ROBERT "BOB" BROOKINS

Chief Technology Officer

Robert “Bob” Brookins, Ph.D., M.A.E. B.A. B.Sc is the Chief Technology Officer. Dr. Brookins served as the CEO of Alexium between 2019 – 2022 and led the organization through developing many of its commercial products. He has experience in organic synthesis, materials chemistry, and chem/bio decontamination. He received his Ph.D. from the University of Florida in the areas of synthesis and characterization of conjugated poly-electrolytes and polymers with an emphasis on developing new polymerization methods. Upon completion of his Ph.D., he worked at the US Air Force Research Laboratory at Tyndall AFB, FL where he developed decontamination methods for chemical and biological threats and developed novel synthetic routes for reactive and functional surfaces. Dr. Brookins now leads Alexium’s R&D, Product Commercialization and Technical groups as the company enters its next growth phase.

BOARD OF DIRECTORS

CARL DENNIS

CARL DENNIS

Non-Executive Director

Mr Dennis is an operational management professional with over 25 years’ experience with expertise in Consumer and Pharmaceutical Goods. As a former CEO and commercial director, Mr Dennis has deep skills in new product development, sales and marketing, international brand management and operational execution. Mr Dennis was the CEO and co-owner of Vital Merchandising Services for 11 years which was acquired by Imperial Logistics Limited in 2007, and he went on to hold both operational and business development roles with Imperial Logistics. Throughout his career, his clients have included Blue Chip FMCG organisations with globally recognised brands.  Over the past five years Mr Dennis has focused in creating new markets for international Australian consumer brands across Asia, Middle East and Africa. Mr Dennis has a Bachelor of Commerce with major in Business Economics from University of the Witwatersrand in Johannesburg.

MR RANDALL LANE

MR RANDALL LANE

Non-Executive Director

Mr. Randall Lane has had an exceptional career in research, manufacturing, start-ups and product commercialization including 25 years of senior management positions in the chemical and medical device industries.
Specifically, he has served as CEO/CSO at CAVU group, comprised of Microtek, American Thermal Instruments and Latent Heat Solutions.  Mr. Lane has also served on several Boards in the private sector.
SIMON MOORE

SIMON MOORE

Non-Executive Director

Simon Moore, a Senior Partner of Colinton Capital Partners, has been appointed as non-executive director. Mr. Moore has over 20 years of experience in senior private equity roles including previously acting as Managing Director and Global Partner of the Carlyle Group. He currently serves on several boards in the roles of NED at Dimero Cleaning Services, NED at AMS Group, Deputy Chairman AMA Group Ltd and Chairman Palla Pharma Ltd.

DR PAUL STENSON

DR PAUL STENSON

Non-Executive Director

Dr. Paul Stenson BSc (Science), PhD (Chemistry) has had a distinguished career with the research, development, manufacture, and commercialization of new materials.  Dr. Stenson is currently President and CEO of StanChem Inc., comprising of two companies – StanChem Polymers, and Albi Protective Coatings. Dr Stenson has over 20 years of experience in senior management positions in the polymer and chemicals industry.  Dr. Stenson is also the chairman of TopChem Pharmaceuticals (Ireland) which is a manufacturer of active pharmaceutical ingredients.

MR MARTYN STRICKLAND

MR MARTYN STRICKLAND

Non-Executive Director

Martyn Strickland is an Operating Partner with Colinton Capital Partners. Martyn joined the firm in June 2017 and represents Colinton Capital Partners on AMSG, Dimeo, Alexium and Clear Dynamics investments.
Prior to joining Colinton Capital Partners, Martyn was a Senior Partner at Deloitte, where he led their middle-market strategy and the Operational Restructuring and CRO services divisions within the Financial Advisory business. In his time as Managing Director with 333 Consulting, he provided leadership, as Principal with A.T.Kearney and as Operating Executive with Cadbury Schweppes.
Martyn has an MBA from the Melbourne Business School and a degree in Mechanical Engineering from the University of Melbourne.